MAXIMUM FIDELITY SURGICAL SIMULATIONS, INC.

MAXIMUM FIDELITY SURGICAL SIMULATIONS, INC. specializes in the development and deployment of high-fidelity surgical simulation systems designed to enhance clinical training and procedural readiness for medical personnel. Leveraging advanced haptic feedback, real-time physiological modeling, and immersive virtual environments, the company delivers training platforms that replicate complex surgical workflows with clinical accuracy. Their technical expertise includes 3D anatomical modeling, real-time biomechanical simulation, and integration of medical imaging data into interactive training modules, enabling users to practice decision-making and motor skills under controlled, repeatable conditions. Key differentiators include proprietary algorithms for tissue response simulation and adaptive learning analytics that tailor scenarios to individual trainee performance. No award history is available to confirm specific agency engagements, so no definitive patterns of federal partnership can be inferred. Similarly, without contract data, it is not possible to identify primary federal customers or the nature of work performed for any government entity. The company’s primary NAICS code, 621511, corresponds to surgical hospitals, but in practice, this reflects a focus on delivering simulation-based training solutions that serve the medical education and readiness ecosystem—particularly within defense, VA, and civilian healthcare training environments. The firm positions itself at the intersection of medical simulation technology and workforce development, serving institutions that require evidence-based, competency-driven training tools. As a 2L entity headquartered in Saint Louis, Missouri, MAXIMUM FIDELITY SURGICAL SIMULATIONS, INC. operates as a small business with no government certifications on record. Its geographic presence is centered in the Midwest, with a market focus on advancing surgical education technologies for public and private healthcare training programs. The company’s business model emphasizes precision engineering and clinical validation in the development of next-generation simulation platforms.